Digital Pathology includes the acquisition, sharing, and interpretation of pathologic information. It is the sub-field of pathology that focuses on data management based on information received from digitalized specimens. Digital pathology is mainly used by large biopharmaceuticals and top clinical research organizations to streamline drug development processes in discovery, clinical trials, and pre-clinical. The growth in digital pathology is boosted due to growing awareness of cancer diagnosis, growing applications of drug development, and precision medicines is propelling the market growth.

Emerging countries are expected to offer potential opportunities to the key players during the coming years.

To a certain extent, the market growth can be hampered due to increasing costs in the digital pathology systems.

Economic Impact of Covid-19:

The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pandemic era of the Global Digital Pathology Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs. Innovations by market players and an increasing number of products will propel the growth of this market.

Digital pathology hardware i.e. scanners are the major restraint in this market. The development of affordable scanners is expected to grow this market, as private medical practices can’t afford expensive digital pathology systems. Therefore, the invention of cost-effective scanners will allow small players to move towards the digitization of pathology workflow creating new opportunities in the digital pathology market.

Key Players:

• Thermo Fisher Scientific Inc
• Apollo Enterprise Imaging Group
• Huron Technologies International Inc.
• PROSCIA
• GE Healthcare
• Propath UK Limited
• Roche Tissue Diagnostics & Visiopharm
• Indica Labs
• Akoya Biosciences
• Ibex Medical Analytics
• Sectra AB
• Inspirata
• Mikroscan Technologies
• Olympus Corporation
• Others

The above key players in the Global Digital Pathology Market can be changed according to the client’s requirements.

Moreover, the key players aim towards expansion, joint ventures, collaboration, mergers, and acquisitions to advance capabilities in Digital Pathology.

Recent Developments in Global Digital Pathology Market.

November 2023: Merge by Merative a leader in medical imaging solutions has signed an

agreement with Indica Labs. This partnership will enable healthcare to integrate digital pathology into merge imaging solutions. Merge by Merative is now able to sell HALO Clinical Solutions for digital pathology with Enterprise Imaging & PACS solutions to enable an integrated ecosystem.

September 2023: In the USA, Evident announced an alliance with Corista, Sakura Finetek USA, and Visiopharm to deliver an automated, end-to-end workflow solution for pathology. They will streamline their workflow of staining, imaging, and analyzing whole-side images with collaboration and management.

Global Digital Pathology Market Key Benefits:

1. The report provides information regarding key drivers, restraints, and opportunities with impact analysis.
2. Quantitative and Qualitative analysis of the current market.
3. Estimations for the forecast period 2032.
4. Historical data and forecast data.
5. Recent developments and trends in the market.   
6. Market share of the market players, company profiles, SWOT analysis, and competitive landscape.
7. Covid-19 Impact analysis

Global Digital Pathology Market Segmentation:

By Type:

• Human Pathology
• Veterinary Pathology

By Application:

• Disease Diagnosis
• Drug Discovery
• mHealth
• Telemedicine

By Therapeutics:

• Hematology
• Oncology
• Autoimmune Disorders
• Others

By End User:

• Hospital & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Diagnostics Centres

Based on Region:

Asia-Pacific

• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia-Pacific

 

North America

• US
• Canada
• Mexico

Europe

• Germany
• France
• Italy    
• Spain
• UK
• Rest of Europe

The rest of the World

Each of the market segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and competitive analysis.

Research Scope:

Report Scope	Details
Base Year	2023
Historical Years	2019 to 2022
Forecast Years	2024 to 2033
Market Size 2023	USD 1.4 BN
Market Revenue 2033	USD 2.3 BN
Growth Rate 2024- 2033	10.9 %
Report Coverage	Trends, SWOT Analysis, Competitive Landscape, DROs, Revenue Forecast, PEST Analysis.
Segments Covered	Type, Application, Therapeutics, End-User, Region
Companies Mentioned	Thermo Fisher Scientific Inc, Apollo Enterprise Imaging Group, Huron Technologies International Inc., PROSCIA, Ge Healthcare, Propath UK Limited, Roche Tissue Diagnostics & Visiopharm, Indica Labs, Akoya Biosciences, Ibex Medical Analytics, Sectra AB, Inspirata, Mikroscan Technologies, Olympus Corporation
Customization	Yes

 

Regional Analysis:

North America dominates over another region with a market share of 40.6% in 2023 due to its deployment of R&D investments, continuous investment, and initiative taken by the government for developing technology in pathology. Furthermore, key players are focusing on various solutions to give a better option to the rising population and the increasing adoption of digital imaging is witnessing the growth of the market in the North American region.

Asia-Pacific is expected to grow with the highest CAGR in the year 2024 to 2032. The growing prevalence of cancer is generating the need for various treatment options further pushing this market to grow in the coming years. Also, rapid digitalization and investments made by key players or governments in medical fields are penetrating developing economies.

In 2023 December, Corista announced a partnership with AGFA Healthcare, a renowned name in diagnostic imaging and IT solutions. This partnership will represent an advancement in healthcare technology with Corista’s DP3 technology with AGFA Healthcare Enterprise Imaging for Pathology.

Key questions answered by this report.

1. Top market players contributing to the revenue?
2. Trending strategies by the players?
3. Which region will be the leading one in the forecast period?
4. Factors that drive the Global Digital Pathology Market?
5. Which factors will affect the Global Digital Pathology Market?
6. How Covid-19 pandemic impacted the growth of the Global Digital Pathology Market?
7. Which Segment accounted for the Global Digital Pathology Market shares?

Frequently Asked Questions (FAQ) :